Georgetown University Law Center, Washington, D.C. (Juris Doctor)
Georgetown McCourt School of Public Policy, Washington, D.C. (Master of Public Policy)
University of California, Los Angeles (Bachelor of Arts in Philosophy and Political Science
Georgetown Public Policy Review, Executive Editor
Mock Trial: Georgetown Law Barristers’ Council, Trial Advocacy, Managing Director
Brent Wisner is an attorney and partner in the Los Angeles office of Baum, Hedlund, Aristei & Goldman, PC. A Los Angeles native, Brent is driven by a deep-rooted passion for using the law to help those who have been marginalized and hurt by large, and sometimes malicious, corporations. Brent has dedicated his practice to vindicating his client’s rights and holding wrongdoers accountable. He concentrates his practice on pharmaceutical class action litigation, toxic-tort injuries, whistleblower and qui tam claims, and consumer fraud litigation. Brent also oversees the firm’s Medicare Secondary Payer cases, representing Medicare providers who have lost taxpayer funds to pharmaceutical companies and other large defendants.
Brent is one of Baum Hedlund’s lead trial attorneys and manages a highly-trained team of attorneys on all aspects of the cases in his department. He takes pride in personally working up all facets of litigation—from briefing, expert discovery, through trial and, if needed, appeal.
Law360 named Mr. Wisner a “Titan of the Plaintiffs Bar” for, in part, his role as co-lead counsel in a complex trial that resulted in the first multi-million-dollar jury verdict against a brand-name drug-maker, GSK, holding it liable for injuries caused by a generic version of the drug Paxil. The case has been described as groundbreaking and likely to shape the landscape of pharmaceutical litigation for years to come. Also, because of this cutting-edge verdict, The National Law Journal recognized Brent and the firm as 2018 Elite Trial Lawyers and the first place winner in the category of Pharmaceutical Litigation.
One of the Leading Zantac Lawyers in the Country
In 2019, Brent and his colleagues filed lawsuits against the manufacturers of Zantac (ranitidine) alleging the popular heartburn medication contains a cancer-causing chemical (NDMA) at levels over 3,000 times greater than the FDA’s legal limit. The lawsuits were among the first of what will likely be many thousands. “Based on recent scientific findings, the levels of NDMA in Zantac are staggering,” says Wisner. “Considering how many people took Zantac in the U.S. since 1983, we are staring into the face of a public health crisis, and these defendants—in particular GSK and Pfizer—are to blame.”
The judge overseeing the multi-district litigation (MDL No. 2924) (where all of the cases filed in federal courts are consolidated) appointed Brent to the Practices and Procedures Team to help establish the protocols and methodology for litigating tens of thousands of cases in the years to come. Brent also serves as Co-Chair of the Zantac Litigation Group for AAJ – American Association for Justice.
Brent’s Appearances Discussing the Zantac Litigation
Zantac Litigation, Master of Mass Tort Conference, Feb. 2020
Status of the Zantac Litigation, American Association of Justice webinar, Jan. 2020
Zantac: Diving into the Science – Harris Martin MDL Conf., Jan. 2020
The Science: NDMA, Ranitidine, and the Risk of Cancer – Harris Martin’s Zantac Litigation Conference, Jan. 2020
Key New Mass Torts: Zantac – Harris Martin Multi-district Litigation Conf., Dec. 2019
Zantac Attack: Over the Counter Carcinogen – Mass Torts Made Perfect Conf., Oct. 2019
Brent Wisner Roundup Cancer Lawyer
Brent Wisner is the only lawyer in the U.S. to serve on all the trial teams for the first three Monsanto Roundup trials. He served as co-lead trial counsel in two of the first three cases, delivering the opening and closing arguments, and cross-examining many of Monsanto’s corporate witnesses.
The juries in the first three trials found that exposure to Monsanto’s Roundup weed killer caused the plaintiffs to develop non-Hodgkin lymphoma, awarding more than $2.424 billion in total damages.
Brent also holds a judge-appointed leadership role as administrator and co-lead counsel for the Roundup Judicial Council Coordination Proceedings (JCCP), which consists of hundreds of Roundup cases consolidated before the California Superior Court for the County of Alameda (state court). He also serves as Liaison Counsel to the Federal MDL-2741 (multi-district litigation) In Re: Roundup Products Liability Litigation for Roundup JCCP 4953 Alameda County.
Daily Journal chooses trial lawyer Brent Wisner among 30 lawyers listed as Top Plaintiff Lawyers in California for the Dewayne Johnson $289M verdict and Pilliod $2B verdict against #Monsanto. Congratulations! pic.twitter.com/2cpgIkovWy
Prior to working at Baum Hedlund, Brent served as a Law Clerk for the Honorable Helen Gillmor in the U.S. District Court for the District of Hawaii for two years. While clerking, he worked on several jury trials, both criminal and civil, and was responsible for aiding the Court in resolving complex pretrial and post-trial motions. In addition, he worked on several cases in other jurisdictions, including the District of Arizona and the Eastern District of California. While clerking, Brent also gained valuable appellate court experience when Judge Gillmor sat on the United States Court of Appeals for the Ninth Circuit in Pasadena, California.
Brent received his law degree (J.D.) and a Master of Public Policy (M.P.P.) from Georgetown University prior to his clerkship. While at Georgetown on a scholarship, he was recognized for his commitment to public interest law and received a pro bono service award for completing over 750 hours of volunteer legal work.
During law school, Brent was heavily involved with the Georgetown Law Trial Advocacy Program, where he was one of the most successful mock trial advocates in the history of the school. Some accolades Brent received at various national competitions included “Top Advocate” at the National Ethics Trial Convention — a competition he also won — and “Most Exceptional Advocate” at the National White-Collar Crime Invitational. Because of Brent’s success with mock trial, he volunteered as a coach and instructor of the team and served as the Managing Director of the Trial Advocacy Program during his third year of law school. In addition to his pro bono work and participation in mock trial, Brent also served as the Executive Editor of the Georgetown Public Policy Review—a peer-reviewed publication focusing on important issues in law and public policy.
Brent also volunteered as a legal intern, during law school, at the Institute on Religion and Public Policy, where he drafted testimony, affidavits, and declarations for legal proceedings that related to human rights. He even wrote a resolution on the imprisonment of Sigma Huda, an outspoken Bangladeshi critic of human trafficking, which passed in the U.S. House of Representatives. During his first summer at law school, Brent worked for the U.S. Attorney’s Office in Los Angeles, within the Civil Fraud Division. It was there that Brent first discovered an interest and passion in whistleblower law. In his second summer of law school, he worked as a Summer Associate at Paul Hastings in the Los Angeles office.
Prior to starting law and graduate school, Brent participated in the prestigious Coro Fellowship. As a Coro Fellow, Brent worked on a variety of important projects with labor unions, local and national government, Fortune 100 companies, and non-profit organizations. It was a formative experience for Brent where he developed a unique insight into how, through the law, one could genuinely improve society.
Brent is an outspoken and passionate UCLA Bruin. He received his undergraduate degree, with honors, in Philosophy and Political Science from the University of California, Los Angeles in 2005. At UCLA, Brent was heavily involved with the UCLA Sailing team, serving as a Captain for two years. In addition, Brent was a Captain on the UCLA Mock Trial Team, which during his last two years won back-to-back National Championships. Brent was also personally recognized as an “All-American Attorney” by the American Mock Trial Association.
Plaintiffs’ Steering Committee, Administrator and Co-Lead Counsel for the Roundup Products Cases, known as the Roundup Judicial Council Coordinated Proceedings (JCCP 4953), California Superior Court for the County of Alameda, California, 2018 – present
Trial Co-Lead Counsel, Wendy B. Dolin vs GlaxoSmithKline LLC (generic Paxil suicide lawsuit), Chicago, Illinois, 2017
Plaintiffs’ Steering Committee / Liaison Counsel for the Cymbalta Drug Cases JCCP 4825 Los Angeles 2015 – present
Trial Co-Lead Counsel, Hagen-Brown vs Eli Lilly (Cymbalta withdrawal lawsuit), Richmond, Virginia, 2015
American Association for Justice: Leader’s Forum; Products Liability; Section on Toxic, Environmental, and Pharmaceutical Torts; Talcum Powder/Ovarian Cancer Litigation Group; Herbicides and Pesticides Litigation Group; Class Action Litigation Group; Preemption Law Litigation Group
Federal Bar Association; Federal Litigation Section; Younger Lawyer Division
Topic: Zantac: A Major Health Crisis Organization: Mass Torts Made Perfect Event: Webinar Date: March 26, 2020
Topic: Zantac litigation Topic: Roundup litigation Organization: Masters of Mass Tort Event: Conference Location: Ritz Carlton, Cancun Date: February 27, 2020
Topic: Status of the Zantac Litigation Organization: AAJ – American Association for Justice Event: Rapid Response Webinar Date: January 31, 2020
Topic: Zantac: Diving into the Science (NDMA, Ranitidine, and the Risk of Cancer) Organization: Harris Martin Event: Harris Martin’s MDL Conference: Zantac, Sex Trafficking and Emerging Mass Tort Litigation Agenda Location: Tampa, Florida Date: January 29, 2020
Topic: The Science: NDMA, Ranitidine, and the Risk of Cancer Topic: Moderator – Class Actions for Consumers & TPPs (Third-Party Payors) Organization: Harris Martin Event: Harris Martin’s Zantac Litigation Conference Location: Miami Beach, Florida Date: January 8, 2020
Topic: Key New Mass Torts: Zantac, Paragard, and HIV Drugs
Topic: Anatomy of a Roundup Trial and the Upcoming Docket Organization: Harris Martin Event: MDL Conference Location: Austin, Texas Date: December 4, 2019
Topic: Zantac Attack: Over the Counter Carcinogen Organization: Mass Torts Made Perfect Event: Seminar Location: The Bellagio, Las Vegas, Nevada Date: October 23, 2019
Topic: $289M Monsanto Roundup Verdict – Life After the Daubert Ruling and Johnson Trial Speech Title: The Johnson Trial and JCCP ( Judicial Council Coordination Proceedings) Organization: Harris Martin Publishing Event: Half-Day Roundup CLE (Continuing Legal Education) Location: Loews Santa Monica Beach Hotel, Santa Monica, California Date: October 24, 2018
Topic: Recent $289M Monsanto Verdict Organization: Harvard University Event: Notable torts case discussion with Professor Jon Hanson’s Tort Law Class Location: Harvard Law School, Cambridge, Massachusetts Date: September 28, 2018
Topic: Cymbalta Withdrawal Litigation In re: Cymbalta (Duloxetine) Products Liability Litigation Organization: American Association for Justice Event: AAJ Education’s Plaintiff-Only Hot Topics and Trends in Litigation Seminar Location: Charleston, South Carolina Date: December 3, 2014
Politics of Enforcement: How the Department of Justice Enforces the Civil False Claims Act, 17 GEO. PUB. POL’Y REV. 43-60, 2012
Judicial Activism? The Roberts Court in the Coming Term, GEO. PUB. POL’Y REV., Dec. 31, 2009
Asylum Denied: Seeking Asylum in the Age of Terrorism, 12 GEO. PUB. POL’Y REV. 21, 2007
Expressing the Sense of the House of Representatives Regarding the Violation of the Human Rights of United Nations Special Rapporteur on Trafficking in Persons, Sigma Huda, and Others, by the Caretaker Government of Bangladesh, H. R. 761, 110th Cong., 2007